lodoxamide   Click here for help

GtoPdb Ligand ID: 9743

Synonyms: Alomide®
Approved drug Immunopharmacology Ligand
lodoxamide is an approved drug (UK (1991), FDA (1993))
Compound class: Synthetic organic
Comment: Lodoxamide is a mast cell stabilizing anti-inflammatory drug. Clinically administered forms may contain lodoxamide trometamol/tromethamine.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 4
Rotatable bonds 6
Topological polar surface area 156.59
Molecular weight 310.99
XLogP -0.34
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl
Isomeric SMILES N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl
InChI InChI=1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21)
InChI Key RVGLGHVJXCETIO-UHFFFAOYSA-N
Bioactivity Comments
The precise mechanism of acton/primary molecular target of mast cell stabilizers is not fully resolved, so we have not associated any protein targets with this drug.
Lodoxamide inhibits the migration of THP-1 cells in vitro, in a GPR35-dependent manner [1].
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
GPR35 Hs Agonist Agonist 9.0 pEC50 - 1
pEC50 9.0 (EC50 1x10-9 M) [1]
Description: In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.